Prevention of stenosis after vascular reconstruction: Pharmacologic control of intimal hyperplasia - A review

Journal of Vascular Surgery

Volumn 13, Issue 6, 1991, Pages 885-891

  Clowes, Alexander W ^a   Reidy, Michael A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FISH OIL; HEPARIN; LOSARTAN POTASSIUM; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY OCCLUSION; DIAGNOSIS; ETIOLOGY; HISTOLOGY; NONHUMAN; PREVENTION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMAL; CONSTRICTION, PATHOLOGIC; ENDOTHELIUM, VASCULAR; GRAFT OCCLUSION, VASCULAR; HEPARIN; HUMAN; HYPERPLASIA; MUSCLE, SMOOTH, VASCULAR; PLATELET AGGREGATION INHIBITORS; SUPPORT, U.S. GOV'T, P.H.S.; WOUND HEALING;

EID: 0025832207     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/0741-5214(91)90055-Y     Document Type: Article

References (59)

1. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation
2. Pathologic intimal hyperplasia as a response to vascular injury and reconstruction
3. Morphogenesis and clinicopathologic characteristics of recurrent carotid disease
4. Long-term follow-up and clinical outcome of carotid restenosis
5. Secondary femoropopliteal reconstruction
6. 5-year results of a prospective study of percutaneous transluminal angioplasty
7. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia
8. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium
9. Mechanisms of stenosis after arterial injury
10. Thrombin generation and fibrin formation following injury to rabbit neointima. Studies of vessel wall reactivity and platelet survival
11. Significance of quiescent smooth muscle migration in the injured rat carotid artery
12. Heparin regulates smooth muscle S phase entry in the injured rat carotid artery
13. Gamma interferon regulates vascular smooth muscle proliferation and Ia espression in vitro and in vivo
14. Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels
15. A morphologic and permeability study of luminal smooth muscle cells after arterial injury in the rat
16. Endothelial regeneration. V. Inhibition of endothelial regrowth in arteries of rat and rabbit
17. Mechanisms of arterial graft failure. II. Choronic endothelial and smooth muscle cell proliferation in healing polytetrafluoroethylene prosetheses
18. The effect of thrombocytopenia on experimental atherosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization
19. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro
20. The pathogenesis of atherosclerosis
21. The pathogenesis of atherosclerosis
22. The role of aspirin in enhancing arterial graft patency
23. Antithrombotic therapy in peripheral vascular disease
24. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery
25. Platelet-derived growth factor (PDGF) stimulates arterial smooth muscle cell proliferation in vivo
26. Regulation of smooth muscle cell growth in injured artery
27. Intimal lesion formation in rat carotid arteries after endothelial denudation in the absence of medial injury
28. Expression of platelet-derived growth factor (PDGF) A- and B-chain gene in smooth muscle during repair of arterial injury
29. 1-Adrenergic stimulation of platelet-derived growth factor A-chain gene expression in rat aorta
30. PDGF ligand and receptor gene expression during repair of arterial injury
31. Induction of insulin-like growth factor I messanger RNA in rat aorta after balloon denudation
32. Influence of chronic hypertension on injured and uninjured arteries in spontaneously hypertensive rats
33. Effect of shear on intimal hyperplasia following arterial injury in rats
34. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury
35. Suppression by heparin of smooth muscle cell proliferation in injured arteries
36. Kinetics of cellular proliferation after arterial injury. IV. Heparin inhibits rat smooth muscle mitogenesis and migration
37. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans
38. Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. in vitro studies
39. An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells
40. Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth
41. Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase
42. Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells
43. The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplasty
44. Restenosis following coronary angioplasty
45. Assessment of the therapeutic use of dietary fish oil in atherosclerotic vascular disease and thrombosis
46. Usefulness of calcium entry blockers during and after percutaneous transluminal coronary artery angioplasty
47. Calcium channel blockers and atherosclerosis
48. Mechanism of antiatherogenic action of calcium antagonists
49. The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition
50. Regulation of smooth muscle proliferation by heparin in vitro and in vivo
51. Kinetics of cellular proliferation after arterial injury II. Inhibition of smooth muscle growth by heparin
52. Inhibition of rat arterial smooth cell proliferation by heparin. I. in vivo studies with anticoagulant and non-anticoagulant heparin
53. Regulation of arterial smooth cell proliferation by heparin in vivo
54. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. II. Evidence for a pentasaccharide sequence that contains a 3-O-sulfate group
55. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells
56. Heparin inhibits tissue plasminogen activator expression in injured rat carotid artery
57. Effect of heparin on interstitial collagenasc and tissue plasminogen activator expression
58. Role of basic fibroblast growth factor in vascular lesion formation
59. Proliferation smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor